DIALYSIS · CCN 332554

FMS-KENMORE ARTIFICIAL KIDNEY CENTER

Tonawanda, NY 14217

DialysisProfitFresenius Medical Care
$2.4M
TOTAL REVENUE
-1.9%
OPERATING MARGIN
2 / 5
STAR RATING
15
QUALITY MEASURES
Fresenius Medical Care
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$2.4M
Total costs
$2.4M
Operating income (rev − costs)
−$44K
Operating margin
-1.9%
Total charges
$2.4M
Total treatments
7,937
Dialysis stations
15

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

15 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
9761—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.8342—
Fistula Rate
DFC_FISTULA_RATE
58.872—
Five Star Rating
DFC_FIVE_STAR
2——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.5940—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
6——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
129.659—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
168—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.17——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2572—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
25.4240—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
10.460—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
37.762—
Standardized ED Visits Ratio
DFC_SEDR
1.1126—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
7.222—